Acesion Pharma
Acesion Pharma is a clinical-stage pharmaceutical company based in Frederiksberg, Denmark, developing novel therapies for atrial fibrillation (AF), the most common cardiac arrhythmia. The company pioneers small-molecule SK ion channel inhibition as a differentiated mechanism to treat AF safely and effectively. Its lead program AP31969 entered Phase 2 clinical trials in January 2026, building on earlier work on the cardioversion candidate AP30663. Acesion Pharma is backed by venture investors including Canaan Partners. As a pharmaceutical R&D company it does not currently publish a public developer API, SDK, or API documentation; this profile captures its corporate identity and public web properties in the API Evangelist network.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Acesion Pharma is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Acesion Pharma scores 9.2/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Resources
Every other property we hold for Acesion Pharma — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Commercial 1
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Acesion Pharma is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/acesion-pharma · machine-readable index on apis.io